Real-time Artificial Intelligence System for Detecting Multiple Ocular Fundus Lesions by Ultra-widefield Fundus Imaging
Status
Conditions
Treatments
Details and patient eligibility
About
This prospective multicenter study will evaluate the efficacy of a real-time artificial intelligence system for detecting multiple ocular fundus lesions by ultra-widefield fundus imaging in real-world settings.
Full description
The ocular fundus can show signs of both ocular diseases (e.g., lattice degeneration, retinal detachment and glaucoma) and systemic diseases (e.g., hypertension, diabetes and leukemia). The routine fundus examination is conducive for early detection of these diseases. However, manual conducting fundus examination needs an experienced retina ophthalmologist, and is time-consuming and labor-intensive, which is difficult for its routine implementation on large scale.
This study will develop an artificial intelligence system integrating with ultra-widefield fundus imaging to automatically screen for multiple ocular fundus lesions in real time and evaluate its performance in different real-world settings. The efficacy of the system will compare to the final diagnoses of each participant made by experienced ophthalmologists.
Enrollment
Sex
Volunteers
Inclusion criteria
All the participants who agree to take ultra-widefield fundus images.
Exclusion criteria
- Patients who cannot cooperate with a photographer such as some paralytics, the patients with dementia and severe psychopaths.
- Patients who do not agree to sign informed consent.
Trial design
2,000 participants in 7 patient groups
Trial contacts and locations
Loading...
Central trial contact
Haotian Lin, MD, PhD; Zhongwen Li, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal